Myologie Fondamentale et Translationnelle

Contrats récents

2018-2020 – Cure CMD –SEPN1-related myopathy: towards new drug therapies

2017-2019 – AFM 2016 – SELNAC: towards a first therapeutic trial for SEPN1-related myopathy

2017-2019 – AFM 2016 – Asc-1, a novel actor in the pathophysiology of congenital muscle disorders

2017-2019 – AFM 2016 – A new mouse model for deminopathies : physiological mechanisms, muscle repair and therapy

2017-2019 – Ligue contre la cardiomyopathie – Caractérisation fonctionnelle des mutations du gène TMPO (LAP2) et de leur mécanisme d’implication dans les cardiomyopathies

2015-2018 – AP-HP (Assistance Publique-Hôpitaux de Paris) PHRC – First clinical trial on SEPN1-related myopathy: randomized, double-blind, cross-over, placebo-controlled phase II-III pilot trial with NAC (SELNAC)

2015-2016 – AFM 2014 – Desminopathies: mutations in desmin, what impact on cell-cell or cell-matrix adhesion?

2014-2017 – ANR Blanc 2013 – Desmin involvement in mechanical properties of skeletal muscle cell

2014-2017 – AFM-Téléthon – MitoSelN

2014-2016 – CEFIPRA (Indo-French Center for the Promotion of Advanced Research) – Muscle stem cell self-renewal: A stressful matter?